Tag: Antibodies

ICMR Study Has Shown Rise In Antibodies Post Covaxin Booster Dose: MoS Health Tells RS
ICMR Study Has Shown Rise In Antibodies Post Covaxin Booster Dose: MoS Health Tells RS

As per the recommendation of the National Technical Advisory Group on Immunization (NTAGI), precaution dose is administered to healthcare workers, frontline workers, and people aged 60 years and above since January 10,2022, she said.

  • Tuesday, 29 March 2022
Antibodies Improve In Quality For Months After Covid Vaccination: Study
Antibodies Improve In Quality For Months After Covid Vaccination: Study

The researchers found that B cells targeted against SARS-CoV-2 persisted in the germinal centres - like boot camps where B cells are trained to make ever-better-quality antibodies - of all participants for months. Even six months after vaccination, 10 out of 15 people still had B cells in their germinal centres.

  • Wednesday, 16 February 2022
Antibodies Down 6 Months After Receiving Vaccine: VIMSAR Findings
Antibodies Down 6 Months After Receiving Vaccine: VIMSAR Findings

As per the study, of the 112 subjects, 11 did not develop antibodies even a month after receiving the first jab. On the other hand, the antibody level in 7 persons had considerably reduced after 6 months of receiving the 2nd dose of Covishield vaccine, found the study.

  • Tuesday, 04 January 2022
Booster Dose Needed?
‘One fourth Of Fully Vaccinated People Will Have No Antibodies’

Almost 20-25 percent of fully inoculated population would not develop antibodies for Covid-19. This information was shared by Director of Institute of Life Sciences (ILS), Ajay Parida on Saturday (Sept 11).

Video Icon
  • Saturday, 11 September 2021
Antibodies-HIV-vaccine
Neutralising antibodies offers hope for HIV vaccine

London: Researchers are in the process of discovering the factors responsible for the production of antibodies that do not just fight one virus strain, but neutralises almost all known virus strains. This kind of neutralising antibodies are produced by a small number of people who are infected with HIV-1. Previously, the team led by the […]

  • Thursday, 08 July 2021
ebola
Potent antibodies against 3 Ebola viruses found

New York: Researchers are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause the lethal disease in humans. The study found that the isolation of two potent monoclonal antibodies from human survivors of Ebola virus disease that — in cell culture studies — efficiently neutralised the […]

  • Thursday, 08 July 2021
Covid-19-cases-in-India
Covid-19 Sero Survey In Bhubaneswar: 50% Population Have Developed Antibodies

Bhubaneswar: In what could decide the future roadmap in the ongoing fight against COVID-19 in the State capital, nearly 50 % residents have developed antibodies against coronavirus infection. The findings were revealed by RMRC Director, Sanghamitra Pati on the basis of the results of the third round of sero-survey conducted in the smart city. In […]

  • Saturday, 10 April 2021
scrollToTop